Ng IO - Search Results

1

Dishevelled-3 phosphorylation is governed by HIPK2/PP1Cα/ITCH axis and the non-phosphorylated form promotes cancer stemness via LGR5 in hepatocellular carcinoma.

Tsui YM, Sze KM, Tung EK, Ho DW, Lee TK, Ng IO. Tsui YM, et al. Among authors: ng io. Oncotarget. 2017 Jun 13;8(24):39430-39442. doi: 10.18632/oncotarget.17049. Oncotarget. 2017. PMID: 28455968 Free PMC article.

2

Doxorubicin-induced apoptosis and chemosensitivity in hepatoma cell lines.

Lee TK, Lau TC, Ng IO. Lee TK, et al. Among authors: ng io. Cancer Chemother Pharmacol. 2002 Jan;49(1):78-86. doi: 10.1007/s00280-001-0376-4. Cancer Chemother Pharmacol. 2002. PMID: 11855756

3

Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression.

Man K, Fan ST, Lo CM, Liu CL, Fung PC, Liang TB, Lee TK, Tsui SH, Ng IO, Zhang ZW, Wong J. Man K, et al. Among authors: ng io. Ann Surg. 2003 Feb;237(2):256-64. doi: 10.1097/01.SLA.0000048976.11824.67. Ann Surg. 2003. PMID: 12560784 Free PMC article.

4

Intragraft gene expression profiles by cDNA microarray in small-for-size liver grafts.

Man K, Lo CM, Lee TK, Li XL, Ng IO, Fan ST. Man K, et al. Among authors: ng io. Liver Transpl. 2003 Apr;9(4):425-32. doi: 10.1053/jlts.2003.50066. Liver Transpl. 2003. PMID: 12682897 Free article.

5

Over-expression of Id-1 induces cell proliferation in hepatocellular carcinoma through inactivation of p16INK4a/RB pathway.

Lee TK, Man K, Ling MT, Wang XH, Wong YC, Lo CM, Poon RT, Ng IO, Fan ST. Lee TK, et al. Among authors: ng io. Carcinogenesis. 2003 Nov;24(11):1729-36. doi: 10.1093/carcin/bgg145. Epub 2003 Aug 29. Carcinogenesis. 2003. PMID: 12949053

6

Disruption of p53-p21/WAF1 cell cycle pathway contributes to progression and worse clinical outcome of hepatocellular carcinoma.

Lee TK, Man K, Poon RT, Lo CM, Ng IO, Fan ST. Lee TK, et al. Among authors: ng io. Oncol Rep. 2004 Jul;12(1):25-31. Oncol Rep. 2004. PMID: 15201954

7

Association of MAD2 expression with mitotic checkpoint competence in hepatoma cells.

Sze KM, Ching YP, Jin DY, Ng IO. Sze KM, et al. Among authors: ng io. J Biomed Sci. 2004 Nov-Dec;11(6):920-7. doi: 10.1007/BF02254377. J Biomed Sci. 2004. PMID: 15591789

8

P21-activated protein kinase is overexpressed in hepatocellular carcinoma and enhances cancer metastasis involving c-Jun NH2-terminal kinase activation and paxillin phosphorylation.

Ching YP, Leong VY, Lee MF, Xu HT, Jin DY, Ng IO. Ching YP, et al. Among authors: ng io. Cancer Res. 2007 Apr 15;67(8):3601-8. doi: 10.1158/0008-5472.CAN-06-3994. Cancer Res. 2007. PMID: 17440071

9

Tissue factor pathway inhibitor-2 as a frequently silenced tumor suppressor gene in hepatocellular carcinoma.

Wong CM, Ng YL, Lee JM, Wong CC, Cheung OF, Chan CY, Tung EK, Ching YP, Ng IO. Wong CM, et al. Among authors: ng io, ng yl. Hepatology. 2007 May;45(5):1129-38. doi: 10.1002/hep.21578. Hepatology. 2007. PMID: 17464989

10

Identification and characterization of tumorigenic liver cancer stem/progenitor cells.

Ma S, Chan KW, Hu L, Lee TK, Wo JY, Ng IO, Zheng BJ, Guan XY. Ma S, et al. Among authors: ng io. Gastroenterology. 2007 Jun;132(7):2542-56. doi: 10.1053/j.gastro.2007.04.025. Epub 2007 Apr 15. Gastroenterology. 2007. PMID: 17570225

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

440 results

Search Page

Filters